BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 567001)

  • 1. [Phosphatases and bone scan in prostatic cancer].
    Urrutia M; Montero J; Grade J; Llopis M
    Actas Urol Esp; 1977; 1(4):207-12. PubMed ID: 567001
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
    Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
    Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation and development of the enzyme activity of phosphatases and the gammagraphic distribution of bone deposits in prostatic cancer (preliminary study)].
    Maganto Pavón E; Mateos Torres JA; Verdú Tartajo F; Boronat Tormo F; Mayayo Dehesa T; Romero Aguirre C
    Actas Urol Esp; 1981; 5(2):93-8. PubMed ID: 7270286
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone scintigraphy, plasma ALP, TAP and PAP in patients with prostatic cancer].
    Imamura A; Hoshi H; Jinnouchi S; Samejima M; Watanabe K
    Kaku Igaku; 1988 Feb; 25(2):177-81. PubMed ID: 3386031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)].
    Kida T; Higuchi Y
    Kaku Igaku; 1981 Aug; 18(7):907-15. PubMed ID: 7321322
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone scanning and plasma phosphatases in carcinoma of the prostate.
    O'Donoghue EP; Constable AR; Sherwood T; Stevenson JJ; Chisholm GD
    Br J Urol; 1978 May; 50(3):172-7. PubMed ID: 753455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bone scanning in the assessment of prostatic carcinoma.
    McGregor B; Tulloch AG; Quinlan MF; Lovegrove F
    Br J Urol; 1978 May; 50(3):178-81. PubMed ID: 753456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
    Merrick MV; Ding CL; Chisholm GD; Elton RA
    Br J Urol; 1985 Dec; 57(6):715-20. PubMed ID: 4084732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone imaging and serum phosphatases in prostatic carcinoma.
    Bishop MC; Hardy JG; Taylor MC; Wastie ML; Lemberger RJ
    Br J Urol; 1985 Jun; 57(3):317-24. PubMed ID: 4005501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
    Johansson JE; Beckman KW; Lindell D; Lingårdh ; Rydman H; Vikterlöf KJ
    Scand J Urol Nephrol Suppl; 1980; 55():31-6. PubMed ID: 6938033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers in cancer of the prostate].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L; Diez E; Pérez Villanueva J
    Actas Urol Esp; 1985; 9(1):79-82. PubMed ID: 4013850
    [No Abstract]   [Full Text] [Related]  

  • 12. The bone scan as a monitor of prostatic cancer.
    Stone AR; Merrick MV; Chisholm GD
    Clin Oncol; 1980 Dec; 6(4):349-60. PubMed ID: 7460409
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
    Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
    Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of serum acid phosphatases, conventional x-ray diagnosis, bone biopsy and Sr 85-bone scanning in the diagnosis of osseous metastases in cancer of the prostate].
    Graber P; Rutishauser G; Baumann JM
    Urologe; 1971 Mar; 10(2):60-2. PubMed ID: 5577980
    [No Abstract]   [Full Text] [Related]  

  • 16. [The acid and alkaline phosphatase activity in the serum of patients with prostatic cancer. The effect of endocrine therapy].
    Thijs LG; Poelman JR; Noll WL
    Ned Tijdschr Geneeskd; 1969 Jul; 113(30):1303-9. PubMed ID: 5802998
    [No Abstract]   [Full Text] [Related]  

  • 17. New assays for prostatic acid phosphatase and alkaline phosphatase isoenzymes.
    Pontes JE
    Urology; 1981 Mar; 17(Suppl 3):38-9. PubMed ID: 7010753
    [No Abstract]   [Full Text] [Related]  

  • 18. [The determination of serum phosphatases].
    Dauchy F
    Presse Med (1893); 1968 Mar; 76(11):523-4. PubMed ID: 5646258
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphography in carcinoma of the prostate.
    Zingg EJ; Fuchs WA; Héritier P; Göthlin J
    Br J Urol; 1974 Oct; 46(5):549-54. PubMed ID: 4420863
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.
    Killian CS; Vargas FP; Pontes EJ; Beckley S; Slack NH; Murphy GP; Chu TM
    Prostate; 1981; 2(2):187-206. PubMed ID: 7301655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.